Dalian BIO-CHEM Company Limited
603360.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥8,067,830 | CN¥1,902,547 | CN¥2,142,617 | CN¥1,665,769 |
| - Cash | CN¥668,244 | CN¥539,524 | CN¥417,963 | CN¥293,879 |
| + Debt | CN¥532,543 | CN¥150,394 | CN¥129,113 | CN¥338,505 |
| Enterprise Value | CN¥7,932,129 | CN¥1,513,417 | CN¥1,853,767 | CN¥1,710,395 |
| Revenue | CN¥1,311,702 | CN¥1,065,661 | CN¥1,256,660 | CN¥1,006,262 |
| % Growth | 23.1% | -15.2% | 24.9% | – |
| Gross Profit | CN¥573,890 | CN¥544,888 | CN¥640,634 | CN¥449,738 |
| % Margin | 43.8% | 51.1% | 51% | 44.7% |
| EBITDA | CN¥463,647 | CN¥440,082 | CN¥516,592 | CN¥353,153 |
| % Margin | 35.3% | 41.3% | 41.1% | 35.1% |
| Net Income | CN¥345,256 | CN¥328,375 | CN¥402,566 | CN¥250,492 |
| % Margin | 26.3% | 30.8% | 32% | 24.9% |
| EPS Diluted | 0.68 | 0.93 | 1.2 | 0.71 |
| % Growth | -26.9% | -22.5% | 69% | – |
| Operating Cash Flow | CN¥162,980 | CN¥389,686 | CN¥479,900 | CN¥142,025 |
| Capital Expenditures | -CN¥74,914 | -CN¥67,352 | -CN¥134,285 | -CN¥191,610 |
| Free Cash Flow | CN¥88,066 | CN¥322,334 | CN¥345,615 | -CN¥49,585 |